Skip to Content
Søk Menu

The 2024 ASCO Genitourinary Cancers Symposium Will Be Covered by BestPractice Nordic

In 2024, BestPractice Nordic will cover the ASCO Genitourinary Cancers Symposium live from the congress.

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Relaterat innehåll

Mansoor Raza Mirza

Mansoor Raza Mirza: ESMO is the Meeting Which Brings New Data for Forever Practice-Changing Trials

/ Mansoor Raza Mirza
ESMO24Gynekologisk cancer Play the Video 04:00
Marc Eid og Karl Semaan

Cancer Epigenomics Improve the Overall Survival and the Quality of Life

/ Marc Eid / Karl Semaan
ASCOGU24Prostatacancer Play the Video 1:31
Wadih Issa

Comparing Downstaging in RCC-Patients with Tumor or Without Tumor Thrombus Receiving Neoadjuvant ICI Regimen

/ Wadih Issa
ASCOGU24Njurcancer Play the Video 1:47
Eddy Saad

Understanding Mechanisms Behind Acquired Resistance to Immunotherapy in Metastatic Renal Cell Carcinoma

/ Eddy Saad
ASCOGU24Njurcancer Play the Video 2:21
Renee Maria Saliby

The Potential for Intermediate Clinical Endpoints as Surrogates for Overall Survival

/ Renee Maria Saliby
ASCOGU24Njurcancer Play the Video 2:46
Philipp Ivanyi

Real-World Evidence on Lenvatinib plus Everolimus in Patients with Pre-Treated Advanced Renal Cell Carcinoma

/ Philipp Ivanyi
ASCOGU24Njurcancer Play the Video 3:16
Ahmed Rehan

Real-World Data on Maintenance Avelumab Treatment

/ Ahmed Rehan
ASCOGU24Blåscancer Play the Video 2:14

ASCO GU 2024: CheckMate 914 Trial – Adjuvant Nivolumab Monotherapy vs Placebo for Localized Renal Cell Carcinoma at High Risk of Relapse After Nephrectomy

/ Sofie Pohl
ASCOGU24Njurcancer
Petros Grivas

Long-Term Patient-Reported Outcomes Data from the JAVELIN Bladder 100 Trial in Patients with Advanced Urothelial Carcinoma

/ Petros Grivas
ASCOGU24Blåscancer Play the Video 02:14
Back to top